ABL1 and breast carcinoma: Evidence suggests that c-Abl activation may lead to the inhibition of mammary tumorigenesis and breast cancer cell mobility and invasiveness [14, 15]; c-Abl activation may also have a role in the process of myelopoiesis [16, 17].